Real-time enrollment status for this duchenne muscular dystrophy clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:44 PM UTC
| NCT Number | NCT03373968 |
| Recruiting Status | Recruiting |
| Condition | Duchenne Muscular Dystrophy |
| Phase | PHASE2 |
| Target Enrollment | 206 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Italfarmaco |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of August 27, 2026: Clinical trial NCT03373968 is currently recruiting participants. This phase2 study for duchenne muscular dystrophy is actively seeking new participants at 10 locations across the United States. The study is sponsored by Italfarmaco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03373968 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03373968 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.